European Journal of Preventive Cardiology

Aims & Scope

The Journal publishes reviews and editorials in order to improve the understanding, prevention, investigation and treatment of cardiovascular diseases.

Pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is cardiac prevention.

Accordingly, submission of manuscripts on clinical and population sciences is invited.

Original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to prevention are also welcome.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	7.5
2024	8.40

Journal Rank

Year	Value
2024	1291

Journal Citation Indicator

Year	Value
2024	4566

SJR (SCImago Journal Rank)

Year	Value
2024	2.119

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	130

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

  Citation: 743

  Authors: Kornelia, David, Dirk, Guy, Lars, Catriona, Viveca, Philippe, Jan, Almudena, Renata, Jaap W, Johan, Mirza, Maryna, Andrejs, Zlatko, Dan, Nina, John, Peter, Aleksandras, Seppo, Dragan, Davor, David, Evagoras, Raphael, Andrzej, Nana, Zeljko, Martin, Stefan, Lale, Dusko

• Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

  Citation: 687

  Authors: Kornelia, Guy, Dirk, Lars, Arno, Diederick, Aldo, Pedro, Catriona, Ana, Carlos, Jolita, Jan, Almudena, Renata, Jim, Kairat, Jaap, Delphine, Johan, Mirza, Marina, Vilnis, Andrejs, Zlatko, Dan, Nina, Peter, Hosam, Piotr, Nebojsa, Seppo, Dragan, Silvia, Linda, Davor, Erkin, Rafael, Nana, Zeljko, Stefan, Lâle, Costas, Dusko, David

• Diabetes as a cardiovascular risk factor: An overview of global trends of macro and micro vascular complications

  Citation: 663

  Authors: Elisa, Antonio, Lars, Marc, Tina B, Oliver, Eberhard, Joline WJ

• 2016 European Guidelines on cardiovascular disease prevention in clinical practice

  Citation: 600

  Authors: Massimo F., Arno W., Stefan, Christian, Carlos, Alberico L., Marie-Therese, Ugo, Bernard, Christi, Ian, Michael Stephen, F. D. Richard, Maja-Lisa, Herbert, Pedro, Joep, Eva, Josep, Dimitrios J., Naveed, Yvo, Monica, H. Bart, Ineke, W. M. Monique, Guy, Marco, Victor, Norbert, Héctor, Scipione, Leslie, John, Johan, Günther, Miles, Donna, Oscar H., Maxime, Catriona, Borut, Paulus, Kornelia, Gregory Y.H., François, Giuseppe, Franz Martin, Alessandro, Alexander, Piotr, Bernhard, Lars, Adrienne, Guillaume, Olov, Stephan, Jose Luis

• Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology

  Citation: 591

  Authors: Marco, Ana, Ugo, Constantinos H, Dominique, Ines, Marie C, Roberto F E, Jean-Paul, Carlo, Heinz, Matthias, Massimo F, Birna, Thomas, Alain, Veronique, Paul, Wolfram, Dan, Andreas B, Hareld, Nicolle, Jari, Miguel, Josef, Maria, Ann-Dorthe Olsen

• EU-Wi<i>d</i>e Cross-Section<i>a</i>l Obser<i>v</i>at<i>i</i>o<i>n</i>al Study of Lipid-Modifying Therapy Use in Se<i>c</i>ondary and Pr<i>i</i>mary Care: the DA VINCI study

  Citation: 548

  Authors: Kausik K, Bart, W Marieke, Periklis, Sarah, Gaia, Jennifer, Maciej, Stefano, Dan, Ioanna, G Kees, Jacek J, J Wouter, Robert Gabor, Serge, Helle K, Vincent, Luis, Alexander, André, Piers, Katarina, Peter, Stefano, Dimitrios, Charalambos, Michal, Alberico L, Neil R

• Insomnia and risk of cardiovascular disease: a meta-analysis

  Citation: 545

  Authors: Francesco, Francesca, Alessandro, Claudio, Rosanna, Gian Franco

• Secondary prevention in the clinical management of patients with cardiovascular diseases. Core components, standards and outcome measures for referral and delivery

  Citation: 479

  Authors: Massimo F, Ugo, Stamatis, Werner, Birna, Margaret, Paul, Patrick, Dan, Stefan, Hannah, Miguel, Josef, Nana, Esteban, Bernhard, Jean Paul, Pantaleo

• Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017

  Citation: 467

  Authors: Nicola Luigi, Wen, Jingxian, Arsalan, Dor, Avishay, Arwa, Haijiang

• Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation

  Citation: 393

  Authors: Alessandro, Larry F, Andrew M, Patrick E, Trine, James A, Axel, Mark A

---